EUVIMEDEUVIMED entdecken
Crossref

Retraction of: Avacopan, a selective C5a receptor antagonist, for anti-neutrophil cytoplasmic antibody-associated vasculitis

Modern Rheumatology · 04.11.2026 · 36 (6) · 1066-1066

DOI: 10.1093/mr/roag060 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Modern Rheumatology, online erschienen am 25.08.2026.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

(2026). Retraction of: Avacopan, a selective C5a receptor antagonist, for anti-neutrophil cytoplasmic antibody-associated vasculitis. Modern Rheumatology, 36(6), 1066-1066. https://doi.org/10.1093/mr/roag060

Vancouver

Retraction of: Avacopan, a selective C5a receptor antagonist, for anti-neutrophil cytoplasmic antibody-associated vasculitis. Modern Rheumatology. 2026;36(6):1066-1066. doi:10.1093/mr/roag060

BibTeX
@article{euvimed2026,
  title = {Retraction of: Avacopan, a selective C5a receptor antagonist, for anti-neutrophil cytoplasmic antibody-associated vasculitis},
  journal = {Modern Rheumatology},
  year = {2026},
  volume = {36},
  number = {6},
  pages = {1066--1066},
  doi = {10.1093/mr/roag060}
}
Kostenlos starten →